Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PUS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | LUC7L3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | EYA3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FAM135A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RIMS3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BTF3L4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TCEA2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CAAP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KLHL11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |